Xpect is a spin-off company of Ghent University and Vrije Universiteit Brussel with a focus on commercializing materials and bio-inks for 3D bioprinting or biofabrication. Leveraging decades of academic experience in the field of polymers and biomaterials, Xpect offers a unique material portfolio with diverse properties, enabling limitless applications. Their bio-inks can be used for various tissue types, making them ideal for regenerative medicine and drug and cosmetics screening.

Xpect also provides a bio-ink portfolio suitable for multiple printing technologies, offering resolutions ranging from hundreds of micrometers to hundreds of nanometers. With a combined 20 years of expertise in polymers, (bio)materials, 3D printing, and tissue engineering, their multidisciplinary team of chemists and biomedical engineers can provide the best solutions for all biofabrication needs. Xpect's partners and advisory board further strengthen their capabilities.

Contact Xpect to learn more about their innovative solutions for the future of bioprinting